Prochlorperazine
Company: IVAX
Approval Status: Approved January 1998
Treatment for: Severe nausea and vomiting, and management of psychotic disorders
Areas: Psychiatry/Psychology
General Information
Other Useful Resources
Prochlorperazine maleate has been approved in 5 mg and 10 mg tablets for the control of severe nausea and vomiting, and for management of the manifestations of psychotic disorders. It is the generic equivalent of SmithKline Beecham's Compazine.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
